These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 31668930)
1. Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States. Sun W; Yang J; Cheng Z; Amrani N; Liu C; Wang K; Ibraheim R; Edraki A; Huang X; Wang M; Wang J; Liu L; Sheng G; Yang Y; Lou J; Sontheimer EJ; Wang Y Mol Cell; 2019 Dec; 76(6):938-952.e5. PubMed ID: 31668930 [TBL] [Abstract][Full Text] [Related]
2. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race. Liu L; Yin M; Wang M; Wang Y Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466 [TBL] [Abstract][Full Text] [Related]
3. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing. Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144 [TBL] [Abstract][Full Text] [Related]
4. Anti-CRISPR AcrIIC3 discriminates between Cas9 orthologs via targeting the variable surface of the HNH nuclease domain. Kim Y; Lee SJ; Yoon HJ; Kim NK; Lee BJ; Suh JY FEBS J; 2019 Dec; 286(23):4661-4674. PubMed ID: 31389128 [TBL] [Abstract][Full Text] [Related]
5. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence. Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726 [TBL] [Abstract][Full Text] [Related]
6. Temperature-Responsive Competitive Inhibition of CRISPR-Cas9. Jiang F; Liu JJ; Osuna BA; Xu M; Berry JD; Rauch BJ; Nogales E; Bondy-Denomy J; Doudna JA Mol Cell; 2019 Feb; 73(3):601-610.e5. PubMed ID: 30595438 [TBL] [Abstract][Full Text] [Related]
7. Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6. Fuchsbauer O; Swuec P; Zimberger C; Amigues B; Levesque S; Agudelo D; Duringer A; Chaves-Sanjuan A; Spinelli S; Rousseau GM; Velimirovic M; Bolognesi M; Roussel A; Cambillau C; Moineau S; Doyon Y; Goulet A Mol Cell; 2019 Dec; 76(6):922-937.e7. PubMed ID: 31604602 [TBL] [Abstract][Full Text] [Related]
8. Cryo-EM structures reveal coordinated domain motions that govern DNA cleavage by Cas9. Zhu X; Clarke R; Puppala AK; Chittori S; Merk A; Merrill BJ; Simonović M; Subramaniam S Nat Struct Mol Biol; 2019 Aug; 26(8):679-685. PubMed ID: 31285607 [TBL] [Abstract][Full Text] [Related]
9. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9. Yang H; Patel DJ Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637 [TBL] [Abstract][Full Text] [Related]
10. Structural and functional insights into the Zuo Z; Zolekar A; Babu K; Lin VJ; Hayatshahi HS; Rajan R; Wang YC; Liu J Elife; 2019 Jul; 8():. PubMed ID: 31361218 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1. Zhu Y; Yin S; Li Z Biochem Biophys Res Commun; 2023 Apr; 654():34-39. PubMed ID: 36878037 [TBL] [Abstract][Full Text] [Related]
12. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease. Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896 [TBL] [Abstract][Full Text] [Related]
13. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins. Zhu Y; Gao A; Zhan Q; Wang Y; Feng H; Liu S; Gao G; Serganov A; Gao P Mol Cell; 2019 Apr; 74(2):296-309.e7. PubMed ID: 30850331 [TBL] [Abstract][Full Text] [Related]
14. Leveraging QM/MM and Molecular Dynamics Simulations to Decipher the Reaction Mechanism of the Cas9 HNH Domain to Investigate Off-Target Effects. Maghsoud Y; Jayasinghe-Arachchige VM; Kumari P; Cisneros GA; Liu J J Chem Inf Model; 2023 Nov; 63(21):6834-6850. PubMed ID: 37877218 [TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the anti-CRISPR, AcrIIC4. Kim GE; Lee SY; Park HH Protein Sci; 2021 Dec; 30(12):2474-2481. PubMed ID: 34676610 [TBL] [Abstract][Full Text] [Related]
17. Real-time observation of Cas9 postcatalytic domain motions. Wang Y; Mallon J; Wang H; Singh D; Hyun Jo M; Hua B; Bailey S; Ha T Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33443184 [TBL] [Abstract][Full Text] [Related]
18. Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion. Shou J; Li J; Liu Y; Wu Q Mol Cell; 2018 Aug; 71(4):498-509.e4. PubMed ID: 30033371 [TBL] [Abstract][Full Text] [Related]
19. Biochemical characterization of RNA-guided ribonuclease activities for CRISPR-Cas9 systems. Gramelspacher MJ; Hou Z; Zhang Y Methods; 2020 Feb; 172():32-41. PubMed ID: 31228550 [TBL] [Abstract][Full Text] [Related]
20. Anti-CRISPR AcrIIC5 is a dsDNA mimic that inhibits type II-C Cas9 effectors by blocking PAM recognition. Sun W; Zhao X; Wang J; Yang X; Cheng Z; Liu S; Wang J; Sheng G; Wang Y Nucleic Acids Res; 2023 Feb; 51(4):1984-1995. PubMed ID: 36744495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]